What the 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease say

29 August 2026 (17:30 - 17:40)

Organised by:

Slides

Sign in for access options

About the speaker

Associate Professor Fabien Praz

University of Bern, Bern (Switzerland)

5 More presentations in this session

Presentation thumbnail

Guidelines in practice: selecting the patient

Doctor M. Sitges (Barcelona, ES)

Presentation thumbnail

The TAVI procedure: live-in-a-box case - a 70-year-old female, asymptomatic with severe aortic stenosis

Doctor M. Joner (Munich, DE)

Presentation thumbnail

The TAVI patient

Doctor T. Rheude (Munich, DE)

Presentation thumbnail

The long-term follow-up of the TAVI patient

Professor O. De Backer (Copenhagen, DK)

Presentation thumbnail

From referral to intervention for aortic stenosis: implementation of the 2025 ESC recommendations for younger and asymptomatic patients - panel discussion

Access the full session

Session thumbnail

From referral to intervention for aortic stenosis: implementation of the 2025 ESC recommendations for younger and asymptomatic patients

The Event

Event poster

ESC Congress 2026

29 August 2026 17:30 CET

You may be interested in

Webinar

The evidence behind the current VHD guidelines. ESC 2021 Clinical Practice Guidelines - Webinar Series

15 June 2022

ESC TV Today

Episode 23: Strategic decisions in valvular heart disease - Optimising drug therapy in chronic coronary syndromes

25 September 2025

Congress Presentation

Indications for surgery in infective endocarditis

25 August 2023

Webinar

The Pregnancy Heart Team unveiled in the 2025 ESC Guidelines: who is in, who benefits, and how to deliver

17 September 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources